Cargando…
A novel mechanism of imeglimin‐mediated insulin secretion via the cADPR‐TRP channel pathway
AIMS/INTRODUCTION: Imeglimin is a novel oral hypoglycemic agent that improves blood glucose levels through multiple mechanisms of action including the enhancement of glucose‐stimulated insulin secretion (GSIS), however, the details of this mechanism have not been clarified. In the process of GSIS, a...
Autores principales: | Funazaki, Shunsuke, Yoshida, Masashi, Yamada, Hodaka, Kakei, Masafumi, Kawakami, Masanobu, Nagashima, Shuichi, Hara, Kazuo, Dezaki, Katsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756313/ https://www.ncbi.nlm.nih.gov/pubmed/34523242 http://dx.doi.org/10.1111/jdi.13669 |
Ejemplares similares
-
cADPR Does Not Activate TRPM2
por: Riekehr, Winnie Maria, et al.
Publicado: (2022) -
Concise Syntheses of Trifluoromethylated Cyclic and Acyclic Analogues of cADPR
por: Huang, Xiangchen, et al.
Publicado: (2010) -
Diabetic ketoacidosis producing extreme hyperkalemia in a patient with type 1 diabetes on hemodialysis
por: Yamada, Hodaka, et al.
Publicado: (2017) -
CD38/cADPR Signaling Pathway in Airway Disease: Regulatory Mechanisms
por: Deshpande, Deepak A., et al.
Publicado: (2018) -
cADPR induced calcium influx mediates axonal degeneration caused by paclitaxel
por: Höke, Ahmet
Publicado: (2022)